{"contentid": 488060, "importid": NaN, "name": "Sandoz in-licenses authorized generic of Proventil HFA", "introduction": "Sandoz Inc has in-licensing of commercial distribution rights to the brand and authorized generic of respiratory inhalation medicine Merck & Co\u00e2\u0080\u0099s Proventil HFA (albuterol sulfate) Inhalation Aerosol from Kindeva Drug Delivery, a global contract development and manufacturing organization supplying the product.", "content": "<p>Sandoz Inc has in-licensing of commercial distribution rights to the brand and authorized generic of respiratory inhalation medicine Merck &amp; Co&rsquo;s (NYSE: MRK) Proventil HFA (albuterol sulfate) Inhalation Aerosol from Kindeva Drug Delivery, a global contract development and manufacturing organization supplying the product.</p>\n<p>The albuterol sulfate authorized generic, a treatment for respiratory diseases, is immediately available to patients in the USA, said Sandoz, the generics and biosimilars arm of Swiss pharma giant Novartis (NOVN: VX).</p>\n<p>There has been a surge in demand for albuterol medicines over the past year. Hospitals increasingly switched to using metered-dose albuterol inhalers rather than nebulizers to treat the growing number of COVID-19 patients. Pharmacies also saw increased demand for albuterol inhalers after the Centers for Disease Control and Prevention (<a href=\"https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/get-ready.html?CDC_AA_refVal=https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/get-ready.html\">CDC) recommended</a> that Americans stock up on necessary medications.<a name=\"_ednref2\"></a></p>\n<p>The entire albuterol sulfate HFA inhalation aerosol market has annual US sales of some $2.8 billion.</p>\n<p>&ldquo;With the commercial distribution rights to the brand and authorized generic of Proventil HFA, we are excited to work to increase supply and help ensure patients who need albuterol have access to this important medicine,&rdquo; said Keren Haruvi, president, Sandoz Inc, adding: &ldquo;This deal delivers on our strategy to grow our respiratory portfolio and brings us closer to our ambition to be the world&rsquo;s leading and most valued generic company.&rdquo;</p>\n<p>Albuterol sulfate is used to treat patients four years and older suffering from bronchospasm, a condition where the muscular coat of the bronchial tubes contracts, resulting in a narrowing of the breathing airways.<a name=\"_ednref3\"></a> &nbsp;Exercise or other physical activities can also bring on symptoms in most people who have asthma and may occur either during or right after being active.<a name=\"_ednref4\"></a><a href=\"https://www.us.sandoz.com/news/media-releases/sandoz-licenses-brand-and-authorized-generic-respiratory-medicine-proventil-hfa#_edn4\"><sup>4</sup></a><sup>/</sup></p>", "date": "2021-03-17 10:03:00", "meta_title": "Sandoz in-licenses authorized generic of Proventil HFA", "meta_keywords": "Kindeva Drug, Merck & Co, Novartis, Sandoz, Genericc, Authorized, Provential HFA", "meta_description": "Sandoz in-licenses authorized generic of Proventil HFA", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-17 09:25:32", "updated": "2021-03-17 10:03:34", "access": NaN, "url": "https://www.thepharmaletter.com/article/sandoz-in-licenses-authorized-generic-of-proventil-hfa", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "sandoz-logo-big.jpg", "image2id": "sandoz-logo-small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Generics", "therapy area_tag": "Respiratory and Pulmonary", "topic_tag": "Deals, Licensing", "geography_tag": "Switzerland, USA", "company_tag": "Kindeva Drug Delivery, Merck & Co, Novartis, Sandoz", "drug_tag": "Proventil HFA", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-17 10:03:00"}